Who can apply: startups, SMEs, research orgs, universities, even individuals — solo or in a consortium.
Grants up to €4M, funded at 100%. Non-dilutive money for bold longevity science.
The EU is funding a moonshot: solving aging itself. 🧬
The EIC just opened a major grant call — Biotechnology for Healthy Ageing. Up to €4M per project, 100% funded.
What it is and how to get in 🧵👇
An EIC Pathfinder Challenge aimed directly at the biology of aging.
Deadline: 28 Oct 2026.
It funds: • age-related interventions • biomarkers for aging • new methods to replace animal testing
We’ve been on there for a while, but just officially launched on @LinkedIn!
Check out our article on what we started a think tank, not a biotech – and please give us a follow over there and share our page with your network. https://t.co/W0pqLkOexP
Aging is arguably the root cause of most major diseases (loss of function in our cells). Four years ago, we made a bet that aging was treatable, and NewLimit was born.
NewLimit now has a prototype drug that reverses the age of some human cells (restores function they had when they were younger), and a clinical trial scheduled for next year (with more drug candidates in the pipeline).
Grateful to Founders Fund, Thrive, Greenoaks, and the rest of the investors for this latest round. @jacobkimmel and the team are just getting started.
The largest-ever lifespan analysis of 601 mTOR modulators is now completed! This project has been driven by Rapamycin Longevity Lab (@omipalRLL) in partnership with @OraBiomedical (CEO @benblueAK, CSO Yan Ting Zhao, AI Engineer Ishan Ranasinghe, Co-founders @mkaeberlein , @BKennedy_aging, @mitchellblee33, @jangruber467 & Jason Pitt). Our mission has been to identify compounds even more potent than Rapamycin in extending lifespan in roundworms.
I am deeply grateful for the community’s support for this historic project and big thanks to all our sponsors who made this possible!
Our Gold Sponsors:
✅ Melissa Burdick & Brian Burdick: Great tech leaders and e-commerce pioneers. Connect with Brian and Melissa on LinkedIn to follow their work.
✅ Antoine Dusséaux: A London-based entrepreneur. Connect with him on X via @adssx
✅ Dmitry Sadovnikov: Connect with him on LinkedIn or X via @ksajxai
✅ Ciarán Murray: A longevity enthusiast and tech founder of @OlasProtocol. Connect with him on X via @C1aranMurray
✅ Anonymous: Two anonymous contributions to the project and one by Anonymouse.
Other Sponsors of the Project:
✅ @agelessrx_ : A cutting-edge telemedicine platform specializing in making various longevity interventions accessible, actively involved in research and clinical trials.
✅ Winslow Strong: Dedicated to advancing human health and wellbeing. Follow him on X @winslow_strong.
✅ Dr. Grant Fraser: Specializes in longevity medicine, integrating lifestyle interventions with personalized medical treatments.
✅ @OpenCuresOrg: A unique online platform empowering individuals, health professionals, labs, and researchers to accelerate longevity interventions.
✅ Revi Health (@johanhedevag): Modern clinic in Sweden combining regenerative medicine, performance health, and longevity protocols for measurable results.
✅ @healthspanmed: The first-ever digital medical clinic helping patients fight cellular senescence and regain control over the levers of aging.
✅ Rapamycin Longevity Lab (@omipalRLL): Our mission is to become the leading expert around mTOR inhibitor-based combinational therapies for longevity.
✅ People in the longevity community: Thank you for every donation, like, and share. Your support has fueled this project!
PS 1: Big thanks also to Victor Björk for the help with the fundraising!
PS 2: All lifespan data is now available on the Rapamycin Longevity Lab’s LID database (link in the comment section). You can find the top 20 and bottom 20 lists right here in the social media image! Big thanks to Andrew Steele (@statto) for the great suggestion to create a bottom list as well!
PS 3: The next step is to collaborate with different parties to analyze the data and also see if the data translates to other species. Reach out if you want to collaborate!
I want elephant-tier TP53.
Humans got 1 gene, 2 alleles. Elephants got ~20 copies because apparently evolution gave them the enterprise plan.
Result: giant, long-lived animals with weirdly low cancer rates.
Meanwhile I’m here with the free version of tumor suppression.